Location: Home
  • search
  • go
  • Relate News
  • 8/27/2021Recent Executive Moves
  • 8/27/2021Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...
  • 8/25/2021IQVIA: Chinese Hospital Drug Market Rose 14.2% in MAT Q2/2021
  • 8/25/2021Alphamab and CSPC Enter Licensing Deal on Anti-HER2 bsAntibody KN026 i...
  • 8/24/2021Review of Top Ten Overseas Out-licensing Deals of Domestic Phama Compa...
  • 8/24/2021IQVIA: Overall Chinese Pharma Market Growth down 7.9% in 2020
  • 8/23/2021BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...
  • 8/23/2021Lonza Expands Guangzhou Manufacturing Facility with a Fill-finish Line
  • 8/23/2021BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
  • 8/20/2021Novartis Receives Approval for Lucentis and Launches Galvus in China
  • 8/20/2021Recent Executive Moves
  • 8/19/2021Adagene Announces the Third Clinical Trial Collaboration with Merck to...
  • 8/18/2021BeiGene and EUSA Pharma Announce NMPA Approval of QARZIBA (Dinutuximab...
  • 8/18/2021HiberCell Takes Over Gentility Science, Formerly Known as WuxiNextcode...
  • 8/18/2021Novartis Secures New Chinese Approval for Cosentyx (Secukinumab) in Pe...
  • 8/18/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation ...
  • 8/17/2021Amgen Secures Chinese Approval of Its Psoriasis Drug Otezla (Apremilas...
  • 8/17/2021CDE Solicits Comments on Technical Guidance for Clinical Trials of New...
  • 8/16/2021IQVIA Provides Snapshot and Outlook of County Level Healthcare Market
  • 8/16/2021Novo Nordisk Launches Once-Weekly Ozempic (Semaglutide) Injection in ...
  • 8/16/2021Incyte and InnoCare Announce Collaboration and License Agreement for T...
  • 8/16/2021CDE Solicits Comments on the Technical Guidance for Research and Evalu...
  • 8/15/2021PharmaDJ: China Strengthens Regulations for Clinical Use of Oncology D...
  • 8/13/2021China's Anti-Foreign Sanctions Law: How Businesses Should Prepare
  • 8/13/2021GC Pharma Announces GreenGene F Approval in China for the Treatment of...
  • 8/12/2021China Issues New Policy on Establishing the Medical Insurance Benefit ...
  • 8/12/2021NHC issues the Guidelines for Long Term Prescription Management (Inter...
  • 8/12/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation...
  • 8/11/2021China Approves Clinical Trial Mixing Covid-19 Vaccines from Sinovac an...
  • 8/11/2021Sinopharm Drops Plan to Take China TCM Holdings Private
  • Page:94/367 Total number of articles:10998: [First][<<] [92] [93] [94] [95] [96] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group